Literature DB >> 22915207

Heart failure as a risk factor for osteoporosis and fractures.

Aloice O Aluoch1, Ryan Jessee, Hani Habal, Melinda Garcia-Rosell, Rehan Shah, Guy Reed, Laura Carbone.   

Abstract

Although heart failure (HF) and osteoporosis are common diseases, particularly in elderly populations, patients with HF have an increased risk for osteoporosis. The relationship of HF with osteoporosis is modified by gender and the severity of HF. In addition, shared risk factors, medication use, and common pathogenic mechanisms affect both HF and osteoporosis. Shared risk factors for these 2 conditions include advanced age, hypovitaminosis D, renal disease, and diabetes mellitus. Medications used to treat HF, including spironolactone, thiazide diuretics, nitric oxide donors, and aspirin, may protect against osteoporosis. In contrast, loop diuretics may make osteoporosis worse. HF and osteoporosis appear to share common pathogenic mechanisms, including activation of the renin-angiotensin-aldosterone system, increased parathyroid hormone levels, and/or oxidative/nitrosative stress. HF is a major risk factor for mortality following fractures. Thus, in HF patients, it is important to carefully assess osteoporosis and take measures to reduce the risk of osteoporotic fractures.

Entities:  

Mesh:

Year:  2012        PMID: 22915207     DOI: 10.1007/s11914-012-0115-2

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  163 in total

Review 1.  Testosterone therapy: treatment of metabolic disturbances in heart failure.

Authors:  Jesse J Naghi; Kiran J Philip; Deanna DiLibero; Robert Willix; Ernst R Schwarz
Journal:  J Cardiovasc Pharmacol Ther       Date:  2010-11-19       Impact factor: 2.457

2.  Zinc inhibits H(2)O(2)-induced MC3T3-E1 cells apoptosis via MAPK and PI3K/AKT pathways.

Authors:  Dan Liang; Maowei Yang; Baolei Guo; Junjun Cao; Lei Yang; XiaoDong Guo; Yuanzhou Li; Zhida Gao
Journal:  Biol Trace Elem Res       Date:  2012-03-21       Impact factor: 3.738

3.  Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

Authors:  Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson
Journal:  J Bone Miner Res       Date:  2007-03       Impact factor: 6.741

4.  Impact of heart failure on hip fracture outcomes: a population-based study.

Authors:  Michael W Cullen; Rachel E Gullerud; Dirk R Larson; L Joseph Melton; Jeanne M Huddleston
Journal:  J Hosp Med       Date:  2011-10-31       Impact factor: 2.960

5.  Risk of atrial fibrillation associated with use of bisphosphonates and other drugs against osteoporosis: a cohort study.

Authors:  Peter Vestergaard; Kristoffer Schwartz; Else Marie Pinholt; Lars Rejnmark; Leif Mosekilde
Journal:  Calcif Tissue Int       Date:  2010-03-23       Impact factor: 4.333

Review 6.  [Diabetes and heart failure: a practically oriented critical appraisal].

Authors:  M Halle; A K Gitt; M Hanefeld; M Kellerer; N Marx; J J Meier; P-M Schumm-Draeger; P Bramlage; D Tschoepe
Journal:  Dtsch Med Wochenschr       Date:  2012-02-21       Impact factor: 0.628

7.  Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II.

Authors:  J E Dinchuk; B D Car; R J Focht; J J Johnston; B D Jaffee; M B Covington; N R Contel; V M Eng; R J Collins; P M Czerniak
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

8.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

Authors:  S G Morham; R Langenbach; C D Loftin; H F Tiano; N Vouloumanos; J C Jennette; J F Mahler; K D Kluckman; A Ledford; C A Lee; O Smithies
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

9.  Endogenous sex hormones and progression of carotid atherosclerosis in elderly men.

Authors:  Majon Muller; Annewieke W van den Beld; Michiel L Bots; Diederick E Grobbee; Steven W J Lamberts; Yvonne T van der Schouw
Journal:  Circulation       Date:  2004-04-19       Impact factor: 29.690

10.  Relation between obesity and bone mineral density and vertebral fractures in Korean postmenopausal women.

Authors:  Kyong-Chol Kim; Dong-Hyuk Shin; Sei-Young Lee; Jee-Aee Im; Duk-Chul Lee
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

View more
  11 in total

1.  What is the optimal level of vitamin D in non-dialysis chronic kidney disease population?

Authors:  Pablo Molina; José L Górriz; Mariola D Molina; Sandra Beltrán; Belén Vizcaíno; Verónica Escudero; Julia Kanter; Ana I Ávila; Jordi Bover; Elvira Fernández; Javier Nieto; Secundino Cigarrán; Enrique Gruss; Gema Fernández-Juárez; Alberto Martínez-Castelao; Juan F Navarro-González; Ramón Romero; Luis M Pallardó
Journal:  World J Nephrol       Date:  2016-09-06

2.  Hyponatremia Is Associated With Increased Osteoporosis and Bone Fractures in a Large US Health System Population.

Authors:  Rachel L Usala; Stephen J Fernandez; Mihriye Mete; Laura Cowen; Nawar M Shara; Julianna Barsony; Joseph G Verbalis
Journal:  J Clin Endocrinol Metab       Date:  2015-06-17       Impact factor: 5.958

3.  Association between prior cancer diagnosis and osteoporosis: a matched case-control study.

Authors:  Shuman Yang; Na Wang; Jianmeng Wang; Lisa M Lix; William D Leslie; Baoming Yuan
Journal:  Arch Osteoporos       Date:  2022-08-12       Impact factor: 2.879

4.  Serum TRACP5b, a Marker of Bone Resorption, Is Associated With Adverse Cardiac Prognosis in Hospitalized Patients With Heart Failure.

Authors:  Satoshi Abe; Akiomi Yoshihisa; Yasuhiro Ichijo; Yusuke Kimishima; Tetsuro Yokokawa; Tomofumi Misaka; Takamasa Sato; Masayoshi Oikawa; Atsushi Kobayashi; Takashi Kaneshiro; Kazuhiko Nakazato; Yasuchika Takeishi
Journal:  CJC Open       Date:  2020-12-13

5.  A Study of Risk Factors for Early-Onset Adjacent Vertebral Fractures After Kyphoplasty.

Authors:  Masayoshi Morozumi; Yuji Matsubara; Akio Muramoto; Yoshinori Morita; Kei Ando; Kazuyoshi Kobayashi; Masaaki Machino; Kyotaro Ota; Satoshi Tanaka; Shunsuke Kanbara; Sadayuki Ito; Naoki Ishiguro; Shiro Imagama
Journal:  Global Spine J       Date:  2019-03-12

6.  Sodium-glucose cotransporter 2 inhibitors do not increase the risk of fractures in real-world clinical practice in Korea: A national observational cohort study.

Authors:  Kyoung Hwa Ha; Dae Jung Kim; Yong Jun Choi
Journal:  J Diabetes Investig       Date:  2022-03-04       Impact factor: 3.681

7.  Plasma Biomarkers for Clinical Assessment of Bone Mineral Density in Heart Transplanted Patients-A Single-Center Study at Skåne University Hospital in Lund.

Authors:  Eveline Löfdahl; Salaheldin Ahmed; Abdulla Ahmed; Göran Rådegran
Journal:  Transpl Int       Date:  2022-03-28       Impact factor: 3.842

Review 8.  Bone in heart failure.

Authors:  Goran Loncar; Natasa Cvetinovic; Mitja Lainscak; Andjelka Isaković; Stephan von Haehling
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-02-22       Impact factor: 12.910

9.  Risk of aortic dissection, congestive heart failure, pneumonia and acute respiratory distress syndrome in patients with clinical vertebral fracture: a nationwide population-based cohort study in Taiwan.

Authors:  Tse-Yen Yang; Ching-Yuan Lai; Feng-You Lee; Wei-Kung Chen; Cheng-Li Lin; Chia-Hung Kao
Journal:  BMJ Open       Date:  2019-11-21       Impact factor: 2.692

10.  Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism.

Authors:  Christian Adolf; Leah T Braun; Carmina T Fuss; Stefanie Hahner; Heike Künzel; Laura Handgriff; Lisa Sturm; Daniel A Heinrich; Holger Schneider; Martin Bidlingmaier; Martin Reincke
Journal:  Endocrine       Date:  2020-06-27       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.